Xiaozhang Zheng

Lexington, MA, United States of America

Xiaozhang Zheng

This inventor holds 114 USPTO granted patents and 45 published patent applications, plus 6 CIPO patents and 13 EPO patents, primarily in HDAC Inhibitors (CPC class C07D471-04). Top assignees: Forma Therapeutics, Inc., Valo Health, Inc., Kymera Therapeutics, Inc.. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaozhang Zheng. Retrieved from https://idiyas.com/inventor/xiaozhang-zheng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 114 

% Patents Active = 93.9

 

 

Average Co-Inventor Count = 6.6

ph-index = 18

Forward Citations = 1,081(Granted Patents)

Forward Citations (Not Self Cited) = 286(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Branford, CT (US) (2003 - 2012)
  • Watertown, MA (US) (2015 - 2024)
  • Lexington, MA (US) (2017 - 2024)

Company Filing History:


Years Active: 2003-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
HDAC Inhibitors
IRAK Degraders
Pyruvate Kinase Activators
NAMPT Inhibition
MDM2 Degraders
Bicyclic Hydroxamic Acids
Sickle Cell Disease Treatment
FASN Inhibition
Crystalline Forms
Amido Derivatives
Piperidine Derivatives
Isoindolines
114 patents (USPTO):Explore Patents

Title: Xiaozhang Zheng: A Visionary Innovator Shaping the Future

Introduction: Xiaozhang Zheng, a prolific inventor based in Lexington, MA (US), has made significant contributions to the world of innovation with his passion for creating solutions that shape the future. With 93 patents to his name, Zheng's relentless pursuit of excellence continues to inspire the next generation of innovators.

Latest Patents: Among his latest inventions are "MDM2 degraders and uses thereof," which provide compounds, compositions, and methods for various applications. Additionally, Zheng's "Alpha-cinnamide compounds and compositions as HDAC8 inhibitors" have shown promise in the treatment of cancer and other diseases, highlighting his versatility in addressing diverse challenges.

Career Highlights: Zheng has lent his expertise to renowned companies such as Forma Therapeutics, Inc., and Valo Health, Inc., where his innovative thinking and problem-solving skills have been instrumental in driving groundbreaking research and development initiatives. His dedication to pushing the boundaries of science and technology has earned him a reputation as a visionary leader in the field.

Collaborations: Throughout his illustrious career, Zheng has collaborated with esteemed colleagues such as Bingsong Han and David R Lancia, Jr., fostering a culture of teamwork and innovation. These partnerships have been instrumental in advancing cutting-edge projects and bringing transformative ideas to fruition.

Conclusion: Xiaozhang Zheng's unwavering commitment to innovation and his remarkable track record of inventions underscore his status as a prominent figure in the world of inventors. His pioneering spirit and dedication to creating impactful solutions continue to shape the landscape of future technologies, leaving a lasting legacy for generations to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…